New drug SYH2085 tested in healthy people for first time
NCT ID NCT07412353
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 1 trial is testing a new drug called SYH2085 in 74 healthy Chinese adults to see if it is safe and how the body processes it. Participants receive either a single dose of SYH2085 or a placebo, and the study also looks at how food affects the drug. This is an early step to gather safety information before testing the drug in people with a medical condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SYH2085 (oral tablet)
- What this could lead to
- If successful, this early study will show that SYH2085 is safe enough to test in people with a disease, but it does not aim to treat any condition yet.
- What could go wrong
- This is a very early Phase 1 trial in only 74 healthy volunteers. It is designed to check safety, not effectiveness, so most drugs at this stage never become treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huashan Hospital Fudan University
RECRUITINGShanghai, Shanghai Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates